Congress Materials – Skin of Color Update (SOCU 2025)
2025 Skin of Color Update | Oct 3-5 | New York, NY
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
The Power of Photos: Leveraging Clinical Photos from the VISIBLE Study to Create an Image Library for Clinicians and Patients
This poster will be available on October 3rd 2025
VISIBLE Cohort A: Guselkumab Skin Clearance Results Through Week 100 in Participants With Moderate-to-Severe Plaque Psoriasis Across All Skin Tones
This poster will be available on October3rd 2025
VISIBLE Cohort A: Long-Term Patient-Reported Outcomes Through Week 100 in Participants With Moderate-to-Severe Psoriasis
This poster will be available on October 3rd 2025
VISIBLE Cohort B: Guselkumab Scalp Clearance Results Through Week 100 in Participants With Moderate-to-Severe Scalp Psoriasis Across All Skin Tones
This poster will be available on October 3rd 2025
VISIBLE Cohort B: Long-Term Patient-Reported Outcomes Through Week 100 in Participants With Moderate-to-Severe Scalp Psoriasis
This poster will be available on October 3rd 2025
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.
